Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Graphite Bio, Inc. | Director | Stock Option (right to buy) | 20K | Jul 19, 2023 | Direct | ||
Jounce Therapeutics, Inc. | Director | Common Stock | 0 | $1.85 | May 3, 2023 | Direct | |
Jounce Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 0 | May 3, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
GRPH | Graphite Bio, Inc. | Jul 19, 2023 | 1 | $0 | 4 | Jul 21, 2023 | Director |
JNCE | Jounce Therapeutics, Inc. | May 3, 2023 | 8 | $0 | 4 | May 4, 2023 | Director |
JNCE | Jounce Therapeutics, Inc. | Jun 24, 2022 | 1 | $0 | 4 | Jun 28, 2022 | Director |
GRPH | Graphite Bio, Inc. | Jun 21, 2022 | 1 | $0 | 4 | Jun 22, 2022 | Director |
GRPH | Graphite Bio, Inc. | Jun 24, 2021 | 0 | $0 | 3 | Jun 24, 2021 | Director |
JNCE | Jounce Therapeutics, Inc. | Jun 18, 2021 | 1 | $0 | 4 | Jun 22, 2021 | Director |
GRPH | Graphite Bio, Inc. | Jan 13, 2021 | 5 | $100K | 4 | Jul 1, 2021 | Director |